Tissue selectivity of the anabolic steroid, 19-nor-4-androstenediol- 3β,17β-diol in male sprague dawley rats: Selective stimulation of muscle mass and bone mineral density relative to prostate mass

Endocrinology

Volumn 149, Issue 4, 2008, Pages 1987-1993

  Page, Stephanie T ^a,d   Marck, Brett T ^b   Tolliver, James M ^c   Matsumoto, Alvin M ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c Drug Enforcement Administration   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

19 NOR 4 ANDROSTENEDIOL 3BETA,17BETA DIOL; ANDROSTANOLONE; ANDROSTENEDIOL DERIVATIVE; GONADOTROPIN; NANDROLONE; SILASTIC; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DRUG CAPSULE; DRUG IMPLANT; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LEVATOR ANI MUSCLE; MALE; MUSCLE MASS; NONHUMAN; ORCHIECTOMY; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE; RAT; SPRAGUE DAWLEY RAT; TISSUE SPECIFICITY;

ANDROSTENEDIOLS; ANIMALS; BODY COMPOSITION; BONE DENSITY; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MUSCLE, SKELETAL; ORGAN SPECIFICITY; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 41549098279     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0956     Document Type: Article

References (42)

1. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL 2005 Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90:1502-1510
2. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL 2004 Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89:503-510
3. Gao W, Dalton JT 2007 Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discov Today 12:241-248
4. Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, Silva de Mendonca J, Falleiros Carvalho LH, Panos G, Pinchera A, Aiuti F, Lee C, Horban A, Gatell J, Phanuphak P, Prasithsirikul W, Gazzard B, Bloch M, Danner SA 2006 Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Med 7:146-155
5. Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T 2006 Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. J Am Soc Nephrol 17:2307-2314
6. Orr R, Fiatarone Singh M 2004 The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. Drugs 64:725-750
7. Yesalis CE 2001 Use of steroids for self-enhancement: an epidemiologic/societal perspective. AIDS Read 11:157-160
8. Schrader Y, Thevis M, Schanzer W 2006 Quantitative determination of metabolic products of 19-norandrostenediol in human plasma using gas chromatography/mass spectrometry. Drug Metab Dispos 34:1328-1335
9. Chung T, Kelleher S, Liu PY, Conway AJ, Kritharides L, Handelsman DJ 2007 Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study. Clin Endocrinol (Oxf) 66:235-245
10. Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ 2003 Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab 88:3167-3176
11. Frisoli Jr A, Chaves PH, Pinheiro MM, Szejnfeld VL 2005 The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci 60:648-653
12. Kuipers H, Wijnen JA, Hartgens F, Willems SM 1991 Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders. Int J Sports Med 12:413-418
13. Toth M, Zakar T 1982 Relative binding affinities of testosterone, 19-nortestosterone and their 5α-reduced derivatives to the androgen receptor and to other androgen-binding proteins: a suggested role of 5α-reductive steroid metabolism in the dissociation of "myotropic" and "androgenic" activities of 19-nortestosterone. J Steroid Biochem 17:653-660
14. Sundaram K, Kumar N, Monder C, Bardin CW 1995 Different patterns of metabolism determine the relative anabolic activity of 19-norandrogens. J Steroid Biochem Mol Biol 53:253-257
15. Behre HM, Kliesch S, Lemcke B, von Eckardstein S, Nieschlag E 2001 Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this nonaromatizable androgen alone. Hum Reprod 16:2570-2577
16. Cunningham GR, Tindall DJ, Means AR 1979 Differences in steroid specificity for rat androgen binding protein and the cytoplasmic receptor. Steroids 33:261-276
17. Windahl SH, Galien R, Chiusaroli R, Clement-Lacroix P, Morvan F, Lepescheux L, Nique F, Horne WC, Resche-Rigon M, Baron R 2006 Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor. J Clin Invest 116:2500-2509
18. Neill US 2006 You say estren, I say estrogen. Let's call the whole replacement off! J Clin Invest 116:2327-2329
19. Manolagas SC, Jilka RL, Kousteni S, Bellido T, Weinstein RS, O'Brien CA, Plotkin L, Han L 2006 Response to Windahl et al. J Clin Invest 116:2834
20. Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298:843-846
21. Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC 2003 Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111:1651-1664
22. Manolagas SC, Kousteni S 2001 Perspective: nonreproductive sites of action of reproductive hormones. Endocrinology 142:2200-2204
23. Saunders FJ, Drill VA 1956 The myotrophic and androgenic effects of 17-ethyl-19-nortestosterone and related compounds. Endocrinology 58:567-572
24. Hershberger LG, Shipley EG, Meyer RK 1953 Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proc Soc Exp Biol Med 83:175-180
25. Gao W, Kim J, Dalton JT 2006 Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands. Pharm Res 23:1641-1658
26. Woodward CJ 1993 A re-evaluation of the anabolic effect of testosterone in rats: interactions with gonadectomy, adrenalectomy and hypophysectomy. Acta Endocrinol (Copenh) 128:473-477
27. Gentry RT, Wade GN 1976 Androgenic control of food intake and body weight in male rats. J Comp Physiol Psychol 90:18-25
28. Sohn EH, Wolden-Hanson T, Matsumoto AM 2002 Testosterone (T)-induced changes in arcuate nucleus cocaine-amphetamine-regulated transcript and NPY mRNA are attenuated in old compared to young male brown Norway rats: contribution of T to age-related changes in cocaine-amphetamine-regulated transcript and NPY gene expression. Endocrinology 143:954-963
29. Haavisto AM, Pettersson K, Bergendahl M, Perheentupa A, Roser JF, Huhtaniemi I 1993 A supersensitive immunofluorometric assay for rat luteinizing hormone. Endocrinology 132:1687-1691
30. Wolden-Hanson T, Marck BT, Smith L, Matsumoto AM 1999 Cross-sectional and longitudinal analysis of age-associated changes in body composition of male Brown Norway rats: association of serum leptin levels with peripheral adiposity. J Gerontol A Biol Sci Med Sci 54:B99-B107
31. Miner JN, Chang W, Chapman MS, Finn PD, Hong MH, Lopez FJ, Marschke KB, Rosen J, Schrader W, Turner R, van Oeveren A, Viveros H, Zhi L, Negro-Vilar A 2007 An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology 148:363-373
32. Ostrowski J, Kuhns JE, Lupisella JA, Manfredi MC, Beehler BC, Krystek Jr SR, Bi Y, Sun C, Seethala R, Golla R, Sleph PG, Fura A, An Y, Kish KF, Sack JS, Mookhtiar KA, Grover GJ, Hamann LG 2007 Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats. Endocrinology 148:4-12
33. van Gammeren D, Falk D, Antonio J 2002 Effects of norandrostenedione and norandrostenediol in resistance-trained men. Nutrition 18:734-737
34. van Gammeren D, Falk D, Antonio J 2001 The effects of supplementation with 19-nor-4-androstene-3,17-dione and 19-nor-4-androstene-3, 17-diol on body composition and athletic performance in previously weight-trained male athletes. Eur J Appl Physiol 84:426-431
35. Colker CM, Antonio J, Kalman D 2001 The metabolism of orally ingested 19-nor-4-androstene-3,17-dione and 19-nor-4-androstene-3,17-diol in healthy, resistance-trained men. J Strength Cond Res 15:144-147
36. Tseng YL, Kuo FH, Sun KH 2005 Quantification and profiling of 19-norandrosterone and 19-noretiocholanolone in human urine after consumption of a nutritional supplement and norsteroids. J Anal Toxicol 29:124-134
37. Tseng YL, Sun CY, Kuo FH 2006 Detection and quantification of glucuro- and sulfoconjugated metabolites in human urine following oral administration of xenobiotic 19-norsteroids. Steroids 71:817-827
38. Kumar N, Sundaram K, Bardin CW 1995 Feedback regulation of gonadotropins by androgens in rats: is 5α-reduction involved? J Steroid Biochem Mol Biol 52:105-112
39. de Gooyer ME, Oppers-Tiemissen HM, Leysen D, Verheul HA, Kloosterboer HJ 2003 Tibolone is not converted by human aromatase to 7α-methyl- 17α-ethynylestradiol (7α-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. Steroids 68:235-243
40. Vanderschueren D, Van Herck E, Suiker AM, Visser WJ, Schot LP, Bouillon R 1992 Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology 130:2906-2916
41. Manolagas SC, Kousteni S, Chen JR, Schuller M, Plotkin L, Bellido T 2004 Kinase-mediated transcription, activators of nongenotropic estrogen-like signaling (ANGELS), and osteoporosis: a different perspective on the HRT dilemma. Kidney Int Suppl 91:S41-S49
42. Manolagas SC, Kousteni S, Jilka RL 2002 Sex steroids and bone. Recent Prog Horm Res 57:385-409